FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Instagram Outage Disrupts Thousands of U.S. Users 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
ADVISORY, Jan. 11, 2017 -- Northrop Grumman Corporation (NYSE:NOC) plans to release its 4th quarter 2016 financial results on Thursday, Jan. 26, 2017. You are invited to participate in a conference call following this release. The information is:
| Date: | Thursday, Jan. 26, 2017 | ||||||||
| Time: | Noon Eastern time, 9 a.m. Pacific time | ||||||||
| Call in by 11:45 a.m. Eastern time, 8:45 a.m. Pacific time | |||||||||
| Call-in Number: | 1-877-600-7013 – domestic | ||||||||
| 1-414-238-0944 – international | |||||||||
A live audio broadcast of the conference call will be available on the Investor Relations page of the Northrop Grumman website at http://www.northropgrumman.com.
For those who cannot participate in this call, it will be archived on the Investor Relations page for a limited time. It will also be recorded and available through Thursday, February 2, 2017, by calling 1-855-859-2056 (domestic) or 1-404-537-3406 (international). Please use conference ID 49165554.
If you have any questions, please call Steve Movius, vice president, Investor Relations, at 703-280-4575 or Denny McSweeny, director, Investor Relations at 703-280-4578.
